The radial artery is protective in women and men following coronary artery bypass grafting-a substudy of the radial artery patency study Background: Studies have demonstrated that female sex is an adverse risk factor in CABG. The primary aim of this study was to determine whether the radial artery (RA) was associated with reduced angiographic occlusion compared to the saphenous vein graft (SVG) stratified by sex in the multi-centered Radial Artery
Introduction
Coronary artery bypass grafting (CABG) remains an effective option for revascularization for those with extensive coronary artery disease. Patients benefit from the durability of this operation with improved survival and freedom from repeat revascularization compared to percutaneous coronary interventions. However, multiple observational studies have shown that despite adjustment for surgical risk using propensity matching or regression analysis, female sex remains a significant risk for both short and late mortality (1, 2) . These differences in outcomes may be attributed to several factors such as differences in female coronary anatomy, revascularization strategy, and the choice of conduits (3) . The importance of graft patency after CABG has been demonstrated in several studies and recently published randomized clinical trials. Graft occlusion or stenosis is associated with repeat revascularization events and mortality. As such, selecting conduits with excellent long-term patency remains an important cornerstone to successful coronary surgery. Understanding the impact of sex on graft patency may lend insight into mechanisms by which mortality outcomes can be improved for women undergoing CABG.
There is some evidence to suggest the use of bilateral internal thoracic arteries (BITA) may reverse the influence of sex on outcomes after CABG (4) . However, BITA utilization remains low in North America and cited reasons for this include technical challenges in conduit harvesting, increased operative time, and concerns for deep sternal wound infections. Female sex has been identified as a risk factor for sternal infection in BITA patients (5) . The length, diameter, and quality of the radial artery (RA) along with excellent wound healing at the site of harvest makes it an excellent conduit for bypass to non-left anterior descending (LAD) targets (6) . Furthermore, the patency of the RA has been shown to be excellent and comparable to that of the left internal thoracic artery (LITA) (7, 8) . In the Radial Artery Patency Study (RAPS), a longitudinal angiographic trial, in addition to the LITA to the LAD, patients were randomized to receive both a SVG and RA to either the left or right coronary arteries using a within patient randomization design whereby patients served as their own control (9, 10) . Radial artery patency exceeded SVG patency at one year and beyond 5 years (approximately 7.5 years) postoperatively (9, 10) . In multivariable analyses, female sex was associated with graft occlusion at the one year and the late angiographic assessment (10, 11) . These findings suggest that female sex may impact graft patency in the long-term and that further research to characterize graft occlusion and stenosis may be important to improving conduit selection and late outcomes in women undergoing CABG.
Here, we explored differences in RA or SVG graft patency by sex from the multi-centred RAPS trial (NCT00187356). Our primary objective was to compare RA versus SVG graft occlusion in women and in men. Our secondary objective was to determine the cumulative patency of both grafts along with predictors of late graft occlusion stratified by sex. The tertiary objective was to compare all-cause mortality, major adverse cardiac events (MACE), defined as cardiac mortality, non-fatal myocardial infarction, and repeat revascularization, and the individual components of MACE between women and men.
Methods
This analysis is a substudy of the Radial Artery Patency Study (RAPS), which has been described extensively elsewhere (9, 10) . In brief, 561 patients less than 80 years of age with triple vessel disease at 13 centers undergoing primary isolated non-emergent CABG were enrolled. In all patients, the LITA was grafted to the LAD. RAPS utilized a within patient randomization design: patients were randomized to have the RA grafted to either the right coronary artery (RCA) or the circumflex region; the SVG would be grafted to the opposing territory (circumflex or RCA). Each patient therefore received both study grafts and served as their own internal control. The target vessel for the RA or SVG was equal to or greater than 1.5 mm with a proximal stenosis of at least 70% by visual inspection on preoperative angiography. All grafts were harvested using an open technique and all CABGs were performed using an on-pump technique. All patients were approached to undergo invasive angiography after 5 years post CABG. Participating sites acquired angiograms digitally, and image sequences were transferred to the main study centre for centralized reading. Patients who declined invasive X-ray angiography were offered the option to undergo computed topography angiography (CTA) and the protocol for this has been detailed elsewhere (9) . In total, 440 patients underwent angiography 1 year post-operatively and 529 patients at nine Canadian centres participated in late follow-up (Figure 1) . Of the 358 that remained alive and eligible for late angiography five years post-operatively, and 269 underwent late angiography (invasive n=234, CTA n=35). Each invasive angiogram was independently adjudicated in a blinded fashion by two interventional cardiologists; a third reviewer was © Annals of Cardiothoracic Surgery. All rights reserved.
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Statistics
Baseline characteristics of patients who underwent longterm follow-up angiography were compared between women and men. Normality of continuous variables was assessed using the Kolmogorov-Smirnov test; a 2-sample t-test and the Wilcoxon rank-sum test was used for parametric and nonparametric continuous variables, respectively. All categorical variables (reported as frequency and percentage) were compared using the Chi-square test or Fisher's exact (n<6). The McNemar's test was used to compare RA versus SVG occlusion within each sex. Comparisons of RA occlusion between women and men, and SVG occlusion between women and men were performed with the Chi-square test. Separate multivariable models were derived to identify predictors of graft occlusion in women and men. Generalized estimating equations (GEE) were used to determine the predictors of complete graft occlusion stratified by sex, as both study grafts were clustered within each patient-the dependent variable was graft occlusion (RA or SVG). Model predictors were selected a-priori based on clinical relevance; these included age at surgery in years, the use of a radial artery (versus study SVG), severity of target proximal native vessel stenosis (70-89% versus >90%), diabetes, hypertension, history of smoking, hyperlipidemia, creatinine (umol/L), and peripheral vascular disease. These covariates were tested for multicollinearity using tolerance statistics; a tolerance value of <0.4 was used as the cutpoint for the presence of multicollinearity. All-cause mortality, MACE, and MACE events were compared between women and men using the Chi-square test and using log-rank statistics. All analyses were performed using SAS (version 9.4; SAS Institute, Inc., Cary, NC, USA). A two tailed P value less than 0.05 was considered statistically significant.
Results

Pre-operative patient and angiographic characteristics
Of the 561 patients randomized in RAPS, there were 269 patients [female, 41 (16.2%), male, 228 (84.8%)] who underwent late angiography at a mean follow-up of 7.7±1.5 years. Women were older (64.1±6.7 versus 59.1±8.0; P<0.01), more likely to be diabetic, and more likely hypertensive compared to male patients ( Table 1) . However, more men were smokers and the baseline creatinine was higher in the male population. Preoperative angiographic characteristics are summarized in Table 1 . There were no differences in the target vessel stenosis by conduit type (RA target vessel versus SVG target vessel) or by coronary system (right versus circumflex target vessel) as assessed by visual inspection at the time of invasive angiography between women and men. The mean number of grafts per patient were similar between women and men (W: 3.8±0.7, M: 3.8±0.6, P=0.65).
Graft occlusion
In both women (26.8% versus 9.8%; P=0.05) and men (17.1% versus 8.8%; P=0.01), the rate of SVG occlusion was significantly higher than that of RA occlusion (Figure 2A) . Between women and men, there was no difference in rates of RA occlusion (9.8% versus 8.8%; P=0.77), SVG occlusion (26.8% versus 17.1%; P=0.14) or any occlusion (34.2% versus 25.4%; P=0.25) ( Figure 2B ). There was no difference in the cumulative patency of RA graft between women and men ( Figure 3A , log rank P=0.69)-the curves were overlapping. When cumulative patency of SVG was examined over time, there was no significant difference in graft patency between women and men, although results in men were consistently numerically higher ( Figure 3B , log 
Predictors of graft occlusion by sex
We compared nine predictors for graft occlusion in a multi-variable GEE model ( Table 2 ). History of smoking was a significant predictor of increased graft failure in men (OR 1.98; 95% CI: 1.27, 3.09; P<0.01). Similarly, elevated creatinine was also a significant predictor of increased graft occlusion in men (OR 1.18; 95% CI: 1.02, 1.36; P=0.02). The degree of target vessel stenosis was protective of graft occlusion in women (OR: 0.13; 95% CI: 0.02, 0.67; P=0.02). In both women (OR: 0.15; 95% CI: 0.03, 0.91; P=0.04) and men (OR: 0.49, 95% CI: 0.26, 0.90; P=0.02), a RA graft was protective from graft occlusion when controlling for other factors.
Clinical endpoints by sex
There was a significant difference in all-cause mortality that was higher in men (12.9%) than women (2.8%, P<0.01). Similarly, cardiac death was higher in men (5.7%) compared to women (0%, P=0.04). There was no difference in the occurrence of MI (2.0% versus 1.4%), need for repeat revascularization by PCI (5.0% versus 5.6%) and major adverse cardiac events (11.8% versus 5.6%) between men and women ( Figure 4) . Cumulative cardiac event free survival was similar between men and women ( Figure 5 ; log rank P=0.14).
Discussion
The most important finding of this substudy of the RAPS trial was that the use of the radial artery as a bypass conduit for grafts to the right coronary or circumflex territories was protective in both women and men. Higher-grade proximal native vessel stenosis was found to be protective against late graft occlusion in women.
These findings are pertinent in the management of advanced CAD in women with implications on addressing the enhanced surgical risk. Early clinical trials of surgical revascularization enrolled mostly men. Later studies suggested that CAD in women may be under-diagnosed or misdiagnosed, and that women were less frequently evaluated with invasive angiography or referred for CABG surgery compared to men of similar profile. Contemporary meta-analysis of observational studies in CABG has shown both early and late mortality to be worse in women compared to men (2). The literature has consistently shown women are more likely to present at an advanced stage of disease with greater severity of symptoms than their male counterparts and with a greater comorbidity burden at the time of surgery (12) . The pattern of distribution of coronary artery disease can exhibit marked sex differences with certain higher grade disease patterns seen in women (13) .
Moreover, earlier studies have demonstrated a lower use of the ITA as a primary graft in women and lower use of a second arterial conduit compared to men, that may account for some of the additional risk seen in women (14, 15) . Kurlansky et al. compared late survival in a retrospective analysis of 602 and 328 propensity matched pairs of men and women that underwent BITA or single ITA grafting respectively (4). The study showed that late survival amongst men and women matched to BITA was comparable at 20 years (31.3% versus 30.1% P=0.790) despite a trend towards lower perioperative survival in women (5.8% versus 3.5%; P=0.055) when treated with single ITA compared to men. An interesting finding in our analysis was the observation that overall survival was better in women than men, contrary to results reported in the literature. In the RAPS trial, all patients enrolled had graftable targets with a high number of grafts performed in both women (16) , and suggests that women are more likely to have incomplete revascularization. Thus, the improved outcomes seen in our study may in part be due to more complete revascularization than is usually achieved in females, and the use of two arterial grafts in all study patients. In a propensity matched analysis of females receiving a RA compared to those receiving SVG at the time of CABG, late Kaplan-Meier estimated survival was higher in women who received RA at 15-year followup (70% versus 58%) (17) . We acknowledge that the differences were unadjusted and the numbers of individual MACE events are small-when the composite MACE outcome was compared between women and men, the Kaplan Meier curves were very similar ( Figure 5) . Consistent with the literature, we showed that the patency was higher with RA compared to SVG; however, in this study we showed that was true in women as well as men. Late follow-up of angiographic outcome studies for the RA have shown consistently high patency rates of greater than 80% at later than seven years of follow-up (8, 18) . In a follow-up of their first 100 patients that underwent CABG with RA grafting, Gaudino et al. showed in 36 patients at 20 years of follow-up a patency rate of 84.4%, comparable to the rate of LITA patency of 93.9% (7) . In contrast, SVG patency was reduced at 45.1% in that same study. In a metaanalysis of RCTs comparing RA or SVG, graft occlusion favored RA at four-year follow-up (19) .
The impetus for this substudy was earlier findings from previous secondary analyses that suggested higher graft occlusion results with women in RAPS. An exploratory analysis of the 440 patients with one-year angiography, revealed that female sex was a multivariable risk factor for graft occlusion (relative risk 1.78, 95% CI: 1.11-2.84, P=0.02), although there was a graft type by sex interaction (RA occlusion similar between women and men, while SVG occlusion was increased in women) (10) . A similar exploratory analysis after late angiography in 269 patients revealed that female sex was a multivariable risk factor for graft occlusion (OR 2.23, 95% CI: 1.14-4.38, P=0.02) (11) . Graft occlusion (of the RA or SVG) was higher in women (34.2% versus 25.4%, Figure 2B ), mainly because of increased SVG occlusion.
Limitations
This study must be interpreted in the context of some important limitations. Any post-hoc subgroup analysis must be considered hypothesis generating or exploratory. In our study, the number of men included was more than fivefold higher than women; this limited sample size may be underpowered to detect differences in clinical outcomes. Furthermore, baseline characteristics were not identical between the groups and we did not adjust for potential known confounders between the groups. Differences in baseline characteristics may explain the profound difference in all-cause mortality between men and women. However, our intergraft comparisons between RA and SVG stratified by sex is not likely impacted by bias, given the within patient randomization design utilized. We also recognize that we have not considered other arterial grafts such as the right ITA. It remains unclear whether a bilateral ITA strategy is superior to that of a LITA/RA strategy (20, 21) .
Conclusions
The use of the radial artery as a second arterial conduit in addition to the use of the internal thoracic artery is appropriate and protective in both women and men with advanced coronary artery disease. Females  65  58  55  54  17  Males  427  386  355  313  117 Log rank P=0.14
Figure 5
Cumulative major adverse cardiac event (MACE) free survival for women (pink) and men (blue). MACE was defined as cardiac mortality, non-fatal myocardial infarction, and repeat revascularization.
